- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced, Refractory Cancer
Total 56535 results
-
M.D. Anderson Cancer CenterCompleted
-
Bispebjerg HospitalDanish Cancer Society; The Novo Nordic Foundation; Lundbeck Foundation; Sygekassernes... and other collaboratorsCompleted
-
University of ChicagoCompleted
-
M.D. Anderson Cancer CenterCompletedAdvanced CancerUnited States
-
CASI Pharmaceuticals, Inc.Completed
-
National Cancer Institute (NCI)WithdrawnAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma
-
AmgenCompletedCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced MalignancyUnited States, Australia
-
NantCell, Inc.CompletedQUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid TumorsCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced Malignancy
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
M.D. Anderson Cancer CenterAmerican Cancer Society, Inc.Completed
-
OHSU Knight Cancer InstituteOregon Health and Science University; Incyte CorporationRecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States, Puerto Rico
-
Sorrento Therapeutics, Inc.WithdrawnSolid Tumor, Adult | Refractory Cancer | Relapsed Solid Neoplasm
-
AmMax Bio, Inc.CompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
University of CincinnatiNot yet recruitingCancer | Metastatic Cancer | Locally Advanced Solid Tumor | Locally Advanced | Locally Advanced CarcinomaUnited States
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
University College, LondonActive, not recruitingGynecologic Cancer | Advanced Cancer | Clear Cell TumorUnited Kingdom
-
Leap Therapeutics, Inc.Pfizer; Merck KGaA, Darmstadt, GermanyTerminatedSolid Tumors | Advanced Triple Negative Breast Cancer | Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer | Advanced Metastatic Castration-Resistant Prostate Cancer | Advanced Platinum-Resistant Ovarian CancerUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Plasma Cell MyelomaUnited States
-
Surface OncologyCompletedHematologic Cancers | Advanced Solid CancersUnited States, Canada
-
Hospices Civils de LyonRecruitingAdvanced Cancer | Sexual SatisfactionFrance
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruitingAdvanced Malignant Cancer
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingAdvanced Malignant Cancer
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Recruiting
-
Sumitomo Pharma America, Inc.CompletedCancer, Advanced MalignanciesCanada, United States
-
University Health Network, TorontoCompleted
-
Kiromic, Inc.TerminatedCancer | Progressive Solid Malignancies | Refractory Solid MalignanciesUnited States
-
Vivolux ABTheradexTerminatedRefractory CancerUnited States
-
Prescient Therapeutics, Ltd.RecruitingAdvanced Cancer | PTCLAustralia
-
Strata OncologyMerck Sharp & Dohme LLC; Pfizer; Gilead SciencesActive, not recruitingCancer | Advanced Solid TumorUnited States
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedAdvanced Solid CancerChina
-
BioPheresis GmbHDr. M. Koehler GmbH; ARTIMED Medical Consulting GmbHTerminatedAdvanced Cancer EntitiesGermany
-
Jiangsu Simcere Pharmaceutical Co., Ltd.UnknownAdvanced or Metastatic Gastric Cancer | Advanced or Metastatic CRC | Advanced or Metastatic Liver Cancer | Advanced or Metastatic Non Squamous NSCLCChina
-
GERCOR - Multidisciplinary Oncology Cooperative...Merrimack PharmaceuticalsCompletedUnresectable Advanced CancerFrance
-
Hanmi Pharmaceutical Company LimitedCompletedSolid Tumor | Advanced CancerKorea, Republic of
-
Sairopa B.V.RecruitingMetastatic Solid Tumor | Solid Tumor, Adult | Refractory CancerUnited States, Moldova, Republic of
-
National Cancer Institute (NCI)CompletedAdvanced Breast Cancer | Advanced Solid Tumors | Primary Peritoneal Cancer | Advanced Ovarian CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant NeoplasmUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Solid Tumors | Treatment-Refractory CancersUnited States
-
M.D. Anderson Cancer CenterCompletedAdvanced CancersUnited States
-
M.D. Anderson Cancer CenterGateway for Cancer Research; Theravalues, Inc.CompletedAdvanced CancersUnited States
-
M.D. Anderson Cancer CenterGE HealthcareWithdrawn
-
M.D. Anderson Cancer CenterCompletedAdvanced CancersUnited States
-
M.D. Anderson Cancer CenterEuropean CommissionCompletedAdvanced CancersUnited States, Spain, France, Israel
-
Aeglea BiotherapeuticsCompletedAdvanced CancersUnited States